AbbVie Inc (ABBV):企業のM&A・提携動向(医療機器分野)

GlobalDataが発行した調査報告書(GDME430057D)
◆英語タイトル:AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME430057D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年2月14日
◆ページ数:46
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company’s products are used to treat Crohn’s disease, cystic fibrosis complications, HIV, low testosterone, Parkinson’s disease, rheumatoid arthritis, psoriasis, thyroid related issues, ulcerative colitis, complications associated with chronic kidney disease and others. AbbVie is also developing products for cancer, renal conditions, immune diseases, hepatitis C virus, women’s health and neurological problems, including Alzheimer’s disease and multiple sclerosis. The company operates through subsidiaries in North America, South America, Asia, Europe, Middle East and South Africa. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc (ABBV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AbbVie Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AbbVie Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AbbVie Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Stem CentRx Raises more than USD100 Million in Financing Round 10
Partnerships 10
Enterome Enters into Co-Development Agreement with AbbVie 10
OraSure Terminates Co-Promotion Agreement with AbbVie for OraQuick 11
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 12
Debt Offering 13
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 13
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 15
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 16
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 18
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 20
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 21
AbbVie Inc – Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 35
Financial Announcements 35
Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results 35
Oct 28, 2016: AbbVie Reports Third-Quarter 2016 Financial Results 37
Jul 29, 2016: AbbVie Reports Second-Quarter 2016 Financial Results 39
Apr 28, 2016: AbbVie Reports First-Quarter 2016 Financial Results 41
Jan 29, 2016: Abbvie Reports Full-Year 2015 And Fourth-Quarter Financial Results 43
Corporate Communications 45
Jan 15, 2016: AbbVie appoints Esteban Plata, Vice President, Western Europe & Canada, replaces Pascale Richetta who retires from AbbVie 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
AbbVie Inc, Medical Equipment, Key Facts, 2015 1
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AbbVie Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AbbVie Inc, Deals By Market, 2011 to YTD 2017 8
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Stem CentRx Raises more than USD100 Million in Financing Round 10
Enterome Enters into Co-Development Agreement with AbbVie 10
OraSure Terminates Co-Promotion Agreement with AbbVie for OraQuick 11
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 12
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 13
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 15
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 16
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 18
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 20
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 21
AbbVie Inc, Key Competitors 24
AbbVie Inc, Key Employees 25
AbbVie Inc, Subsidiaries 26

List of Figures
AbbVie Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
AbbVie Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AbbVie Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AbbVie Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ AbbVie Inc (ABBV):企業のM&A・提携動向(医療機器分野)(AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆